一种新型股动脉电动压迫装置用于股动脉穿刺后止血的安全性和有效性。
Safety and effectiveness of a novel electric femoral artery compression device for hemostasis after femoral artery puncture.
作者信息
Zhong Zhihong, Ni Hongyang, Chen Xiao, Zhu Jun, Jiang Hong, Hu Jinqing, Lin Dong, Bian Liuguan
机构信息
Department of Neurosurgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
出版信息
Front Neurol. 2025 May 19;16:1582310. doi: 10.3389/fneur.2025.1582310. eCollection 2025.
OBJECTIVE
This study aimed to investigate the hemostatic efficacy of a novel electric femoral artery compression device in patients who underwent percutaneous endovascular procedure through femoral artery puncture.
METHODS
We retrospectively reviewed 1,086 patients treated with the electric compression device (ECD) and/or vascular closure device (VCD) for hemostasis of femoral catheterization sites. The clinical success of hemostasis and complications of femoral artery puncture site were collected and analyzed.
RESULTS
A total clinical success rate of 84.8% was achieved. Minor complications occurred in 161 of 1,086 patients (14.8%), and major complications occurred in 4 of 1,086 patients (0.4%). Combined application of ECD and VCD showed a lower rate of complications than using ECD or VCD alone in patients who underwent treatment of antiplatelet agents and anticoagulant.
CONCLUSION
ECD is a safe and effective tool for hemostasis in femoral artery puncture site in percutaneous endovascular procedure with high clinical success and low complication rates.
目的
本研究旨在探讨一种新型股动脉电动压迫装置在经股动脉穿刺进行经皮血管腔内手术患者中的止血效果。
方法
我们回顾性分析了1086例接受电动压迫装置（ECD）和/或血管闭合装置（VCD）进行股动脉穿刺部位止血治疗的患者。收集并分析了止血的临床成功率及股动脉穿刺部位的并发症情况。
结果
总体临床成功率为84.8%。1086例患者中有161例（14.8%）发生轻微并发症，1086例患者中有4例（0.4%）发生严重并发症。在接受抗血小板药物和抗凝治疗的患者中，ECD和VCD联合应用的并发症发生率低于单独使用ECD或VCD。
结论
ECD是经皮血管腔内手术中股动脉穿刺部位止血的一种安全有效的工具，临床成功率高，并发症发生率低。
Zotero 插件